Related Experiment Video
Updated: Jul 19, 2025

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
Published on: January 5, 2024
Thrombosis in multiple myeloma: mechanisms, risk assessment and management
Osnat Jarchowsky1,2, Orly Avnery1,2, Martin H Ellis1,2
1Hematology Institute, Meir Medical Center, Kfar SabaIsrael.
Abstract:
Multiple myeloma (MM) is associated with an increased risk of venous and arterial thrombosis. Pathophysiologic mechanisms include patient, disease and treatment related factors. Risk assessment models have been developed to determine whichpatients are at highest thrombotic risk and pursuant to this, risk adapted thrombosis prophylaxis has been suggested. Areas in which further basic and clinical research is imperative include the molecular and cellular mechanisms of thrombosis in myeloma, the inclusion of relevant biomarkers in risk assessment scores and controlled clinical trials of VTE prophylaxis and treatment using direct oral anticoagulants.
Insights
Multiple myeloma patients face higher thrombosis risks due to disease and treatment factors. Further research is needed for better risk assessment and prophylaxis strategies.
Area of Science:
- Hematology
- Oncology
- Thrombosis Research
Background:
- Multiple myeloma (MM) significantly elevates the risk of both venous and arterial thrombosis.
- Thrombosis risk in MM is multifactorial, involving patient-specific, disease-related, and treatment-induced elements.
Purpose of the Study:
- To review the current understanding of thrombosis in multiple myeloma.
- To identify key areas for future research in MM-associated thrombosis.
Main Methods:
- Literature review and synthesis of existing data on MM and thrombosis.
- Analysis of pathophysiologic mechanisms and risk assessment models.
Main Results:
- Established risk factors for thrombosis in MM patients include disease activity and specific therapies.
- Current risk assessment models aid in identifying high-risk individuals for thrombosis.
Conclusions:
- Risk-adapted thrombosis prophylaxis strategies are recommended for MM patients.
- Further research into molecular mechanisms, biomarkers, and clinical trials for anticoagulation is crucial.
More Related Videos
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Venous Thrombosis I: Introduction
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care